Bisdemethoxycurcumin inhibits Wnt/β-catenin pathway by increasing WIF-1 expression, which subsequently leads to suppression of TGF-β1-induced EMT migration. - GreenMedInfo Summary

Abstract Title:

Abstract Source:

Abstract Author(s):

Abstract:

Study Type : In Vitro Study

Additional Links

Substances : Bisdemethoxycurcumin : CK(35) : AC(19), Curcumin : CK(4844) : AC(2458)

Diseases : Carcinoma: Non-Small-Cell Lung : CK(264) : AC(161), Lung Cancer : CK(1741) : AC(742), Lung Cancer: Metastatic : CK(40) : AC(15)

Pharmacological Actions : Anti-metastatic : CK(1284) : AC(927), Wnt/β-catenin pathway down-regulation : CK(49) : AC(27)

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy